肿瘤坏死因子样配体1A与风湿病的关系
摘要
肿瘤坏死因子样配体1A(tumornecrosisfactor—likeligand1A,TL1A)是近年来发现的一种属于肿瘤坏死因子(tumornecrosisfactor,TNF)超家族的新成员。TL1A可以作用于T淋巴细胞影响机体的免疫应答,且在炎症的发病过程中,炎症细胞分泌的TL1A水平明显升高,它还可以促进其他炎症细胞因子的合成及分泌,在风湿病中发挥重要作用。
出处
《临床荟萃》
CAS
2013年第4期453-456,共4页
Clinical Focus
参考文献29
-
1Tan KB, Harrop J,Reddy M, et al. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells[J]. Oene, 1997,204(1/2) : 35-46.
-
2Migone TS, Zhang J, Luo X, et al. TIAA is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator [J]. Immunity, 2002,16(3) z479 492.
-
3Bamias G, Siakavellas SI, Stamatelopoulos KS, et al. Circulating levels of TNF-like cytokine IA (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis[J]. Clin Immunol,2008,129 (2) :249-255.
-
4Hayash/ S, Miura Y, Nishiyama T, et al. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis [ J ]. Arthritis Rheum, 2007, 56 (4) : 1067-1075.
-
5Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword [J ]. Nat Rev Immunol, 2003,3 ( 9 ) : 745- 756.
-
6Osawa K, Takami N, Shiozawa K, et al. Death receptor 3 (DR3) gene duplication in a chromosome region lp36.3;gene duplication is more prevalent in rheumatoid arthritis[J]. GenesImmun,2004,5(6):439-443.
-
7Zhang J, Wang X, Fahmi H, et at. Role of TL1A in the pathogencsis of rheumatoid arthritis[J]. J Immunol, 2009,183 (8) :5350-5357.
-
8Pappu BP, Borodovsky A, Zheng TS, et al. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease[J]. J Exp Med, 2008,205 (5) : 1049-1062.
-
9Wan X, Shi G, Semenuk M, et aI. DcR3/TR6 modulates immune cell interactions[J]. J Celt Biochem,2003,89(3) :603- 612.
-
10Shi G,Wu Y, Zhang J, et al. Death decoy receptor TR6/DcR3 inhibits T cell chemotaxis in vitro and in vivo[J]. J Immunol, 2003,171 (7) : 3407-3414.
二级参考文献29
-
1Tan KB, Harrop J, Reddy M, et al. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene, 1997, 204:35.
-
2Giorgos B, Charles M, Marco M, et al. Cominelli, Expression, lo- calization, and functional activity of TL1 A, a novel Thl -polarizing cy- tokine in inflammatory bowel disease. J Immunol, 2003, 171:4868.
-
3Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol, 2003, 3:745.
-
4Bull MJ, Williams AS, Mecklenburgh Z, et al. The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in in- flammatory arthritis. J Exp Med, 2008, 205 : 2457.
-
5Zhang J, Wang XH, Fahmi H, et al. Role of TL1 A in the pathogen-esis of rheumatoid arthritis. J Immunol, 2009, 183 : 5350.
-
6Cassatella MA, Pereira-da-Silva G, Tinazzi I, et al. Soluble TNF- Like Cytokine (TL1 A) Production by Immune Complexes Stimulated Monocytes in Rheumatoid Arthritis. J Immunol, 2007, 178:7325.
-
7Bamias G, Siakavellas SI, Stamatelopoulos KS, et al. Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis. Clin Immunol, 2008, 129 : 249.
-
8Bresnihan B. Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol, 1999, 26:717.
-
9Lane KL, Shannon RJ, Weiss SW. Hyalinizing spindle cell tumor with giant rosettes--a distinctive tumor closely resembling lowgrade fibromyxoid sarcoma. Am J Surg Pathol, 1997,21:1481-1488.
-
10Wordruff JM, Antonescu CR, Erlandson RA, et al. Low-grade fibrosarcoma with palisaded granulomalike bodies (giant rosettes ):report of a case that metastasized. Am J Surg Pathol, 1999, 23:1423-1428.
共引文献6
-
1贾军会,李慎涛,刘振龙,赵文明.重组人IL-17A和IL-17F的制备方法及活性测定[J].生物技术通报,2011,27(4):137-142.
-
2熊林波,张弛,谢羽婕,胥方元.白细胞介素家族与骨关节炎相关性研究[J].西南军医,2011,12(6):1104-1106. 被引量:3
-
3薛妍,林星,吴茂春,刘城亮,王长连.类风湿关节炎患者血清TL1A和IL-17的测定及相关因素分析[J].中国当代医药,2013,20(18):46-47. 被引量:1
-
4郭迪斌,谷晓晶,居艳娟,甘风英,李荣平,王飙,陈琥.类风湿关节炎患者血清可溶性髓样细胞触发受体-1、白介素-17水平研究[J].中国医学创新,2013,10(32):15-17. 被引量:3
-
5唐朝,武永利,张艳玲.膝骨性关节炎不同中医证型患者血清IL-17、IL-18水平的变化[J].宁夏医科大学学报,2014,36(7):728-730. 被引量:5
-
6赵瑞雪,刘岩,凌琬茗,刘晓霞,陈银肖.血清LECT2、TL1A水平对特应性皮炎患儿病情的诊断价值[J].国际检验医学杂志,2024,45(18):2240-2243.
-
1薛妍,林星,吴茂春,刘城亮,王长连.类风湿关节炎患者血清TL1A和IL-17的测定及相关因素分析[J].中国当代医药,2013,20(18):46-47. 被引量:1
-
2陈伟玲,冯怿霞,单彩燕.益赛普治疗强直性脊柱炎48例的观察与护理[J].中国误诊学杂志,2010,10(23):5691-5691. 被引量:1
-
3王冬雪,谢瑶,舒晓明,马丽,王国春,李红艳.类风湿关节炎患者外周血TL1A表达水平及其临床意义[J].内科急危重症杂志,2011,17(6):337-339. 被引量:4
-
4薛妍,林星,王长连.TL-1A和IL-17在类风湿关节炎中的作用及其临床意义[J].中国当代医药,2013,20(16):25-27. 被引量:1
-
5卢宝全,李薇,张瑛琪.肿瘤坏死因子α拮抗剂与感染风险[J].临床荟萃,2009,24(6):549-551.
-
6周敏,刘蕊,李霞,孙凌云.肿瘤坏死因子样配体1A对类风湿关节炎患者外周血Th17产生及分化的调节作用[J].中华风湿病学杂志,2013,17(8):518-521.
-
7吴春玲,杨娉婷,刘海娜,赵丽娟,肖卫国.依那西普联合来氟米特治疗强直性脊柱炎的临床分析[J].中国全科医学,2011,14(24):2754-2757. 被引量:17
-
8高冠民,蒋莉,刘升云,刘章锁,张国俊,陈奎生.重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白对肺间质病变大鼠TGF—β1表达的影响[J].中华风湿病学杂志,2008,12(11):754-756. 被引量:1
-
9熊成,邢学梅,李冠霖.TNF抑制剂依那西普治疗强直性脊柱炎60例分析[J].中国误诊学杂志,2012,12(3):650-651. 被引量:2
-
10刘燕鹰,常丽丽,栗占国.类风湿关节炎患者外周血中糖皮质激素诱导的肿瘤坏死因子受体相关基因及其配体的表达和意义[J].北京大学学报(医学版),2007,39(2):163-166. 被引量:4